News About: Pharm. Industry
SK Chemicals will enter the “global blood” product marketSK Chemicals has taken the first step to enhance and specialize in its new growth engine, the blood product business.
SK Chemicals (CEO Man-hoon Park) announced on the 7th that...
|
Samsung Pharm has established the partnership with the largest distribution company to expand to ChinaSamsung Pharm (President Ik-woo Lee) has established the foundation to expand to China by signing memorandum of understanding (MOU) to make a strategic partnership with the larg...
|
Dong-A Pharmaceutical took over the Bayer’s 4 contraceptive products such as ‘Myvlar’
Dong-A Pharmaceutical (President and CEO Dong-wook Shin) announced on the 6th that it has taken over the 4 oral contraceptive products of Bayer, ‘Myvlar,’ ‘Meliane,’ ‘Minivlar,’ and ‘Triquilar.’
This takeover is the ...
Cosmetics of pharmaceutical companies have diversified distribution channels by expanding to pharmacies
For the last 6 months, launches of pharmacy cosmetic brands of pharmaceutical companies have continued, diversifying distribution channels.
That is, products of cosmeceutical, combining ‘cosmetic’ and ‘pharmaceutic...
Since the enforcement of the Patent Linkage System, approximately 1,600 patent trials were claimed
Since the enforcement of the Pharmaceutical Patent Linkage System on 15 March, it is known that approximately 1,600 cases of patent trials were claimed.
B2Pharm (CEO Hong-gi Lee), a pharmaceutical data analysis compa...
Ilsung Pharmaceuticals and Huons made the exclusive sale contract for the arteriosclerosis drug ‘Arigrel’Ilsung Pharmaceuticals (CEO Suk-geun Yoon) and Huons (CEO Jae-gab Jeon) held a signing ceremony of their exclusive sale contract for the arteriosclerosis treatment ‘Arigrel’ on ...
|
Will multinational pharmaceutical companies experience fluctuation in the sale rank?
It is known that sales of the top multinational pharmaceutical companies in Korea deceased a little last year, but their rank was not changed much.
According to recent audit reports turned by 31 multinational compani...
3 pharmaceutical companies were indicated by the many in the rebate ‘secret voting’
It is known that despite the trend of the pharmaceutical companies’ transparent ethical management, illegal business activities, such as rebates, have still been made.
The Korea Pharmaceutical Manufacturers Associati...
Celltrion has acquired approvals for Remsima in 13 of the 22 South American countriesCelltrion announced on the 29th that Remsima has been approved to sell from Instituto Nacional de Higiene Rafael Rangel in Venezuela. Thus, Celltrion is now able to sell Remsima...
|
The generic market of ‘celecoxib’ is heated up along with approvals of 45 products only in this year
The arthritis treatment ‘celecoxib’ generic market has attracted the industry.
According to the Ministry of Food and Drug Safety, 103 generic products of ‘celecoxib,’ whose patent will be expired on the coming 11th o...
